PGR and neoplasm: The subgroups were homogenous with respect to age, race, breast (left or right), smoking status, presence of collagen vascular disease, tumor grade, pathologic T stage, estrogen receptor positivity, progesterone receptor positivity, radiation field design, fractionation schedule, and dose max (>110% prescription dose).